Assessment of Immature Platelet Fraction in the Diagnosis of Wiskott–Aldrich Syndrome

Frontiers in Pediatrics

Volumn 3, Issue , 2015, Pages

  Sokolic, Robert ^a   Oden, Neal ^b   Candotti, Fabio ^c,d  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^b EMMES CORPORATION   (United States)

^c NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^d LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

differential diagnosis; immature platelet fraction; immune thrombocytopenic purpura; thrombocytopenia; Wiskott Aldrich syndrome

Indexed keywords

EID: 84942522001     PISSN: None     EISSN: 22962360     Source Type: Journal    
DOI: 10.3389/fped.2015.00049     Document Type: Article

References (30)

1. Buchanan GR. Thrombocytopenia during childhood: what the pediatrician needs to know. Pediatr Rev (2005) 26:401–9.
2. Arnold DM Patriquin D Toltl LJ Nazi I Kelton J. Diseases of platelet number. 6 ed. In: Hoffman R Benz EJ Silberstein LE Heslop HE Weitz JI Anastasi J, editors. Hematology: Basic Principles and Practice. Philadelphia, PA: Elsevier (2013). p. 1883–93.
3. Neunert C Lim W Crowther M Cohen A Solberg L Jr Crowther MA. The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia. Blood (2011) 117:4190–207.10.1182/blood-2010-08-30298421325604
4. Redelmeier DA. Improving patient care. The cognitive psychology of missed diagnoses. Ann Intern Med (2005) 142:115–20.10.7326/0003-4819-142-12_Part_1-200506210-0002215657159
5. Filipovich AH Stone JV Tomany SC Ireland M Kollman C Pelz CJ et al. Impact of donor type on outcome of bone marrow transplantation for Wiskott-Aldrich syndrome: collaborative study of the International Bone Marrow Transplant Registry and the National Marrow Donor Program. Blood (2001) 97:1598–603.10.1182/blood.V97.6.159811238097
6. Moratto D Giliani S Bonfim C Mazzolari E Fischer A Ochs HD et al. Long-term outcome and lineage-specific chimerism in 194 patients with Wiskott-Aldrich syndrome treated by hematopoietic cell transplantation in the period 1980-2009: an international collaborative study. Blood (2011) 118:1675–84.10.1182/blood-2010-11-31937621659547
7. Shin CR Kim MO Li D Bleesing JJ Harris R Mehta P et al. Outcomes following hematopoietic cell transplantation for Wiskott-Aldrich syndrome. Bone Marrow Transplant (2012) 47:1428–35.10.1038/bmt.2012.3122426750
8. Braun CJ Boztug K Paruzynski A Witzel M Schwarzer A Rothe M et al. Gene therapy for Wiskott-Aldrich syndrome – long-term efficacy and genotoxicity. Sci Transl Med (2014) 6:227ra33.10.1126/scitranslmed.300728024622513
9. Candotti F Shaw KL Muul L Carbonaro D Sokolic R Choi C et al. Gene therapy for adenosine deaminase-deficient severe combined immune deficiency: clinical comparison of retroviral vectors and treatment plans. Blood (2012) 120:3635–46.10.1182/blood-2012-02-40093722968453
10. Chinen J Davis J De Ravin SS Hay BN Hsu AP Linton GF et al. Gene therapy improves immune function in preadolescents with X-linked severe combined immunodeficiency. Blood (2007) 110:67–73.10.1182/blood-2006-11-05893317369490
11. Thrasher AJ Hacein-Bey-Abina S Gaspar HB Blanche S Davies EG Parsley K et al. Failure of SCID-X1 gene therapy in older patients. Blood (2005) 105:4255–7.10.1182/blood-2004-12-483715687233
12. Huntley CC Dees SC. Eczema associated with thrombocytopenic purpura and purulent otitis media; report of five fatal cases. Pediatrics (1957) 19:351–61.
13. Patel PD Samanich JM Mitchell WB Manwani D. A unique presentation of Wiskott-Aldrich syndrome in relation to platelet size. Pediatr Blood Cancer (2011) 56:1127–9.10.1002/pbc.2292021488158
14. Mantadakis E Sawalle-Belohradsky J Tzanoudaki M Kanariou M Chatzimichael A Albert MH. X-linked thrombocytopenia in three males with normal sized platelets due to novel WAS gene mutations. Pediatr Blood Cancer (2014) 61:2305–6.10.1002/pbc.2519625154619
15. Skoric D Dimitrijevic A Cuturilo G Ivanovski P. Wiskott-Aldrich syndrome with macrothrombocytopenia. Indian Pediatr (2014) 51:1015–6.10.1007/s13312-014-0550-5
16. de Martino M Galli L Azzari C Zammarchi E Vierucci A. Effect of different intravenous immunoglobulin regimens on hemorrhages, platelet numbers and volume in a child with Wiskott-Aldrich syndrome. Vox Sang (1994) 67:317–9.10.1111/j.1423-0410.1994.tb01260.x
17. Briggs C. Quality counts: new parameters in blood cell counting. Int J Lab Hematol (2009) 31:277–97.10.1111/j.1751-553X.2009.01160.x19452619
18. Vinholt PJ Hvas AM Nybo M. An overview of platelet indices and methods for evaluating platelet function in thrombocytopenic patients. Eur J Haematol (2014) 92:367–76.10.1111/ejh.1226224400878
19. Koike Y Miyazaki K Higashihara M Kimura E Jona M Uchihashi K et al. Clinical significance of detection of immature platelets: comparison between percentage of reticulated platelets as detected by flow cytometry and immature platelet fraction as detected by automated measurement. Eur J Haematol (2010) 84:183–4.10.1111/j.1600-0609.2009.01364.x
20. Meintker L Haimerl M Ringwald J Krause SW. Measurement of immature platelets with Abbott CD-Sapphire and Sysmex XE-5000 in haematology and oncology patients. Clin Chem Lab Med (2013) 51:2125–31.10.1515/cclm-2013-025223800658
21. Pons I Monteagudo M Lucchetti G Munoz L Perea G Colomina I et al. Correlation between immature platelet fraction and reticulated platelets. Usefulness in the etiology diagnosis of thrombocytopenia. Eur J Haematol (2010) 85:158–63.10.1111/j.1600-0609.2010.01468.x20477866
22. Abe Y Wada H Tomatsu H Sakaguchi A Nishioka J Yabu Y et al. A simple technique to determine thrombopoiesis level using immature platelet fraction (IPF). Thromb Res (2006) 118:463–9.10.1016/j.thromres.2005.09.00716253312
23. Briggs C Kunka S Hart D Oguni S Machin SJ. Assessment of an immature platelet fraction (IPF) in peripheral thrombocytopenia. Br J Haematol (2004) 126:93–9.10.1111/j.1365-2141.2004.04987.x15198738
24. Wiskott A. Familiarer angeborener Morbus Werlhofii? Monatsschr Kinderheilkd (1937) 68:212–6.
25. Ochs HD Slichter SJ Harker LA Von Behrens WE Clark RA Wedgwood RJ. The Wiskott-Aldrich syndrome: studies of lymphocytes, granulocytes, and platelets. Blood (1980) 55:243–52.
26. Sabri S Foudi A Boukour S Franc B Charrier S Jandrot-Perrus M et al. Deficiency in the Wiskott-Aldrich protein induces premature proplatelet formation and platelet production in the bone marrow compartment. Blood (2006) 108:134–40.10.1182/blood-2005-03-121916522820
27. Sullivan KE Mullen CA Blaese RM Winkelstein JA. A multiinstitutional survey of the Wiskott-Aldrich syndrome. J Pediatr (1994) 125:876–85.10.1016/S0022-3476(05)82002-57996359
28. Ochs HD Nelson DL Stiehm ER. Other well-defined immunodeficiency syndromes. 5 ed. In: Stiehm ER Ochs HD Winkelstein JA, editors. Immunologic Disorders in Infants and Children. Philadelphia, PA: Elsevier Saunders (2004). p. 505–79.
29. Provan D Stasi R Newland AC Blanchette VS Bolton-Maggs P Bussel JB et al. International consensus report on the investigation and management of primary immune thrombocytopenia. Blood (2010) 115:168–86.10.1182/blood-2009-06-22556519846889
30. Strauss G Vollert C von SA Weimann A Gaedicke G Schulze H. Immature platelet count: a simple parameter for distinguishing thrombocytopenia in pediatric acute lymphocytic leukemia from immune thrombocytopenia. Pediatr Blood Cancer (2011) 57:641–7.10.1002/pbc.2290721826780